Colistin for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
Objectives: To investigate clinical and microbiological response, and 30-day mortality of pneumonia involving multidrug-resistant (MDR) Acinetobacter calcoaceticus-Acinetobacter baumannii (Acb) complex treated with colistin, and identify associated factors of these outcomes. Methods: A retrospective...
Main Authors: | Jun-Yuan Zheng, Shie-Shian Huang, Shu-Huan Huang, Jung-Jr Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118219301409 |
Similar Items
-
Pharmacodynamics of colistin against Acinetobacter baumannii
by: Mohd Rasidin, Rashizal Sazli
Published: (2017) -
Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
by: Shi H, et al.
Published: (2019-12-01) -
Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin
by: Yu-Mu Chen, et al.
Published: (2014-10-01) -
Risk Factors Associated With Colistin-Resistant Acinetobacter baumannii Infection
by: Hae-Sun Chung, et al.
Published: (2023-06-01) -
Colistin-Resistant Acinetobacter baumannii as a cause of Neonatal Ventriculitis
by: Prasha Mahabeer, et al.
Published: (2018-09-01)